Metastatic Colorectal Cancer - PEAK Study - Bethesda MD (Clinical Trial 6198) (Clinical Trial 6198)
Permalink: http://www.ClinicalConnection.com/PatientViewStudy6198.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please search our
studies.
|
|
 |
 |
|
| City: |
|
Bethesda |
| State: |
|
MD |
| Zip Code: |
|
20817 |
|
|
|
|
|
|
| Study summary: |
|
Individuals with colorectal cancer that has metastasized (spread) are invited to inquire about participation in a clinical research study. This study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it will extend survival for a longer period of time, compared to the best available standard of care regimen. Monoclonal antibodies are substances produced in a laboratory that can locate and bind to cancer cells by recognizing specific substances on cancer cells. These antibodies are used to find and attack tumors.
|
| Qualified participants must: |
|
• Have unresectable (inoperable) colorectal cancer that has metastasized (spread)
•
Be at least 18 years of age
•
Not have received a prior treatment regimen for their advanced-stage colorectal cancer
•
Meet other enrollment criteria |
| Participants will receive: |
|
Study-related medication and study-related procedures at no cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials or take the Participation
Quiz to find out if you are a good candidate for clinical trial
participation.
|
|
|
|
|